Both will develop cancer vaccine candidates in selected haematological and solid tumour indications
Category: mRNA
The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359
pharmaceuticals.co.nz
Drugs, medicines and medical news